A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.

Abstract

To better understand the pathogenesis of type 1 diabetes, our group performed a pathological examination on the pancreas tissue of recent-onset type 1 diabetics and analysed their clinical characteristics. These studies led us to speculate that there are three distinct subtypes of type 1 diabetes mellitus: autoimmune, nonautoimmune fulminant and nonautoimmune nonfulminant (or nonautoimmune chronic). The autoimmune type 1 diabetes mellitus comprises about 60% of the patients and is characterized by insulitis and over-expression of class I MHC molecules in the islet cells, a high prevalence of diabetes-related autoantibodies, and a progressive loss of beta-cell function after the onset of diabetes. The nonautoimmune nonfulminant type 1 diabetes mellitus includes about 30% of the patients, shows neither insulitis nor over-expression of class I MHC antigen in the islet cells, and has a low prevalence of diabetes-related autoantibodies and a relatively slow progression of beta-cell loss after the onset of diabetes. The nonautoimmune fulminant type 1 diabetes comprises about 10% of patients and shows neither insulitis nor over-expression of class I MHC molecules, but is characterized by lymphocytic infiltration in the exocrine pancreatic tissue, elevated serum pancreatic enzyme levels, absence of diabetes-related autoantibodies and a remarkably aggressive course of disease. The appropriate classification of type 1 diabetes would increase our understanding of the pathogenesis of the disease and would allow to develop therapeutic means based on this understanding.

• Authors: A Imagawa, T Hanafusa, J Miyagawa, Y Matsuzawa
• Journal: Annals of medicine (Ann Med) Vol. 32 Issue 8 Pg. 539-43 (Nov 2000) ISSN: 0785-3890 [Print] England
• PMID: 11127931 (Publication Type: Journal Article, Review)

Chemical References

• Autoantibodies

Topics

• Autoantibodies (immunology)
• Autoimmune Diseases (classification)
• Diabetes Mellitus, Type 1 (classification, immunology)
• Humans
• Islets of Langerhans (immunology, pathology)
• Major Histocompatibility Complex (immunology)